Dear Dr. Suravajhala,
My name is Aleksandra Skalska, and I’m the Publishing Manager for
Academia Immunity and Disease, an open-access journal led by our Editor-in-Chief, Dr. Chunfu Zheng (University of Calgary, Canada). The journal is associated with
Academia.edu, a global research platform with over 300 million registered researchers.
We are currently welcoming high-quality submissions for our journal and would be delighted to consider an original research article or review within your area of expertise.
Please note that we would be happy to offer you a full waiver of the article processing charge if the paper is submitted by
mid-July 2026.
One of the main reasons authors choose to publish with us is the early visibility and
readership their work receives on the Academia.edu platform. We have had the privilege of publishing influential papers, such as:
Aducanumab:
advancing Alzheimer’s treatment through regulation of excessive β-amyloid accumulation -
24,310 views, 5,679 downloads, 1 citation
MHC-II
polymorphism in tuberculosis control: general lessons from focused studies in mice -
2,802 views, 733 downloads
Would this opportunity align with your current research projects? We’d be very pleased to consider your latest work, and you’re welcome to reach out with any questions or submit directly
here.
We look forward to hearing from you.
Best regards,
Aleksandra Skalska, PhD
Academia Immunity and Disease Editorial Office
-----